CellerateRX Surgical Powder
Commercial- Indications
- Surgical wounds, Surgical site infection prevention
Company intelligence / Profile preview
Sanara MedTech has a commercial-stage portfolio of advanced wound care and surgical tissue repair products. The company’s marketed offerings include activated collagen powders/gels for wound healing, antimicrobial cleansers/irrigation solutions to reduce infection risk, amniotic membrane allografts for soft tissue repair, extracellular matrices for bone/tissue regeneration, and other biologic devices. In recent years the company has expanded its intellectual property portfolio with new provisional patents focused on antimicrobial technologies and hydrolyzed collagen. Financial results show strong revenue growth (~33% YoY in FY2024), improved profitability in core segments, and continued investment into R&D.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanara MedTech.